BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders

  November 19, 2024

   · 

  5 min read
• Press Releases

  Convergent Therapeutics Announces First Shipments of Actinium 225 from Cardinal Health to Support the CONVERGE-01 Phase 2 Clinical Trial

  November 19, 2024

   · 

  3 min read
• Press Releases

  CF Foundation Invests Up to $15 million in ReCode Therapeutics to Develop a Gene Editing Therapy

  November 19, 2024

   · 

  2 min read
• Press Releases

  KaliVir Immunotherapeutics Strengthens Innovation Portfolio with Issuance of Three New U.S. Patents Covering Its VET™ Product Candidates

  November 19, 2024

   · 

  2 min read
• Press Releases

  Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue

  November 19, 2024

   · 

  6 min read
• Press Releases

  Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

  November 19, 2024

   · 

  4 min read
• Press Releases

  Fresenius Medical Care’s AI-Powered Application of the Anemia Control Model Selected for CMS AI Demo Days in the United States

  November 19, 2024

   · 

  4 min read
• Press Releases

  Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence

  November 19, 2024

   · 

  5 min read
• Press Releases

  NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer

  November 19, 2024

   · 

  5 min read
• Press Releases

  Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency

  November 19, 2024

   · 

  7 min read